Human BAF170 (SMARCC2) and BAF155 (SMARCC1), the homologs of Swi3p, are involved in cancers since BAF170 and BAF155 mutations were found in gastric and colorectal cancers and small cell lung cancers, respectively [41,42]. Here, SMARCC1 is linked to small cell lung carcinoma.